A carregar...
Tumor Hypoxia Response After Targeted Therapy in EGFR-Mutant Non-Small Cell Lung Cancer: Proof of Concept for FMISO-PET
Hypoxia is associated with resistance to radiotherapy and chemotherapy. Functional imaging of hypoxia in non-small cell lung cancer (NSCLC) could allow early assessment of tumor response and guide subsequent therapies. Epidermal growth factor receptor (EGFR) inhibition with erlotinib reduces hypoxia...
Na minha lista:
| Publicado no: | Technol Cancer Res Treat |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4565779/ https://ncbi.nlm.nih.gov/pubmed/25759424 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1533034615574386 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|